Related Experiment Video
Updated: Apr 22, 2026

10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
19.1K
Migraine headache prophylaxis in adolescents
Nursing for Women'S Health
|October 16, 2014
Summary
Topiramate is the first FDA-approved medication for adolescent migraine prevention. Adequate education on its benefits and risks is crucial for young patients and their families.
Area of Science:
- Neurology
- Adolescent Medicine
- Pharmacology
Background:
- Migraine headaches affect up to 28% of adolescents, predominantly females.
- Chronic migraine in adolescents leads to decreased quality of life and missed school days.
- Historically, migraine treatment focused on episodic management rather than prevention.
Purpose of the Study:
- To highlight the significance of the FDA approval of topiramate for migraine prophylaxis in adolescents.
- To emphasize the need for comprehensive patient and family education regarding topiramate's use.
Main Methods:
- Review of the FDA approval of topiramate (Topamax®) in March 2014.
- Discussion of topiramate's role in migraine prevention for adolescents aged 12-17.
- Identification of potential adverse effects associated with topiramate.
Main Results:
- Topiramate is the first drug approved by the FDA for migraine prevention in the adolescent population.
- The approval marks a shift towards preventative treatment strategies for adolescent migraines.
- Potential for serious adverse effects necessitates thorough patient counseling.
Conclusions:
- The FDA approval of topiramate offers a new preventative option for adolescent migraines.
- Informed decision-making requires a clear understanding of both the benefits and risks of topiramate.
- Ongoing education for adolescents and families is imperative for safe and effective migraine management.
Related Concept Videos
Mania and Antimanic Drugs: Overview
785
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
785
Pharmacokinetics in Pediatric Patients: Drug Excretion
395
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
395
Drug Dosing: Infants and Children
972
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
972
Antiasthma Drugs: Methylxanthines
1.9K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.9K
Mitral Valve Prolapse III: Nursing Management
568
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
568
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.1K

